Natural Product: NPC606568

Natural Product IDNPC606568
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
CMKFQVZJOWHHDV-NQZBTDCJSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2163793
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey CMKFQVZJOWHHDV-NQZBTDCJSA-N
Standard InCHI InChI=1S/C21H24N2O2/c1-3-14-10-13-11-21(20(24)25-2)18-16(8-9-23(12-13)19(14)21)15-6-4-5-7-17(15)22-18/h4-7,10,13,19,22H,3,8-9,11-12H2,1-2H3/t13-,19+,21-/m0/s1
SMILES CCC1=C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@](C(=O)OC)(C2)[C@@H]13

  Calculated Properties

Physi-Chem Properties

MedChem Properties

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

ADMET: Distribution

ADMET: Metabolism

ADMET: Excretion

ADMET: Toxicity

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[ 3619437]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. DOI[10.1002/btpr.97]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. DOI[10.1007/s11738-010-0631-6]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/j.plaphy.2018.10.015]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. DOI[10.1080/17429145.2017.1293852]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. DOI[10.1186/1750-2187-3-9]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[12628396]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota Hairy roots n.a. n.a. PMID[19271765]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[26285573]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[6619887]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[6631435]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[7264679]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[7264682]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[7320741]
NPO62806 Catharanthus roseus (L.) G. Don Genus Apocynaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO60916 Vinca rosea Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1002/bit.27575]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1002/bit.28040]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1007/s10529-023-03357-z]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1007/s13213-015-1074-5]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.bej.2020.107655]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.enzmictec.2020.109557]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.jbiotec.2013.10.017]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.jbiotec.2014.05.018]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.jbiotec.2016.11.031]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.mec.2022.e00215]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.meteno.2018.02.001]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.ymben.2015.07.007]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.ymben.2017.09.006]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.ymben.2017.12.009]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.ymben.2019.06.004]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.ymben.2022.01.013]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.ymben.2022.11.002]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1016/j.ymben.2023.01.005]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1021/acs.jafc.2c02353]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1021/acs.jafc.9b03456]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1021/acssynbio.2c00026]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1021/acssynbio.2c00037]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1021/acssynbio.2c00047]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1021/acssynbio.5b00289]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1021/acssynbio.7b00439]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1038/s44160-022-00205-2]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1039/D1GC00260K]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1073/pnas.1423555112]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1073/pnas.1501821112]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1080/09168451.2019.1693250]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1128/AEM.01249-09]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1128/AEM.01983-12]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1186/1475-2859-12-77]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.1186/s13068-018-1176-y]
NPO65083 A new engineered strain of Pichia pastoris Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.3390/jof8080767]
NPO65071 A new engineered strain of Saccharomyces cerevisiae Species n.a. n.a. n.a. n.a. n.a. DOI[https://doi.org/10.34133/bdr.0002]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5881 Catharanthus roseus Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1885 Individual protein Transient receptor potential cation channel subfamily M member 8 Mus musculus Activity n.a. n.a. n.a. PMID[25052206]
NPT2719 Individual protein Voltage-gated L-type calcium channel alpha-1C subunit Rattus norvegicus IC50 = 8400.0 nM IC50 data for the L-type calcium channel extracted from a set of literature articles
NPT1885 Individual protein Transient receptor potential cation channel subfamily M member 8 Mus musculus IC50 = 700.0 nM PMID[25052206]
NPT346 Individual protein Transient receptor potential cation channel subfamily A member 1 Homo sapiens Activity = 78.0 % PMID[25052206]
NPT1885 Individual protein Transient receptor potential cation channel subfamily M member 8 Mus musculus EC50 n.a. n.a. n.a. PMID[25052206]
NPT346 Individual protein Transient receptor potential cation channel subfamily A member 1 Homo sapiens EC50 = 9000.0 nM PMID[25052206]
NPT1885 Individual protein Transient receptor potential cation channel subfamily M member 8 Mus musculus IC50 n.a. n.a. n.a. PMID[25052206]
NPT2719 Individual protein Voltage-gated L-type calcium channel alpha-1C subunit Rattus norvegicus IC50 = 224000.0 nM IC50 data for the L-type calcium channel extracted from a set of literature articles
NPT346 Individual protein Transient receptor potential cation channel subfamily A member 1 Homo sapiens IC50 n.a. n.a. n.a. PMID[25052206]
NPT1885 Individual protein Transient receptor potential cation channel subfamily M member 8 Mus musculus IC50 = 900.0 nM PMID[25052206]
NPT346 Individual protein Transient receptor potential cation channel subfamily A member 1 Homo sapiens Activity n.a. n.a. n.a. PMID[25052206]
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 4.527 % Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = 2.61 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = 0.99 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT67 Individual protein Cholinesterase Equus caballus IC50 = 5170.0 nM PMID[23062825]
NPT67 Individual protein Cholinesterase Equus caballus Inhibition = 75.23 % PMID[23062825]
NPT472 Individual protein Vanilloid receptor Homo sapiens IC50 n.a. n.a. n.a. PMID[25052206]
NPT66 Individual protein Acetylcholinesterase Electrophorus electricus IC50 n.a. n.a. n.a. PMID[23062825]
NPT472 Individual protein Vanilloid receptor Homo sapiens Activity = 13.0 % PMID[25052206]
NPT472 Individual protein Vanilloid receptor Homo sapiens EC50 = 20000.0 nM PMID[25052206]
NPT66 Individual protein Acetylcholinesterase Electrophorus electricus Inhibition = 5.28 % PMID[23062825]
NPT439 Individual protein Butyrylcholinesterase Homo sapiens IC50 = 3170.0 nM PMID[23062825]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = -7.57 % Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.36 % Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC606568 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC314333
0.6623 Remote Similarity NPC329858
0.6456 Remote Similarity NPC482061
0.6375 Remote Similarity NPC485936
0.6375 Remote Similarity NPC485937
0.5783 Remote Similarity NPC485938
0.5116 Remote Similarity NPC473041
0.5114 Remote Similarity NPC187106
0.5057 Remote Similarity NPC96321
0.5057 Remote Similarity NPC111993

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC606568 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD4499 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data